Bmal1 upregulates ATG5 expression to promote autophagy in skin cutaneous melanoma

Abstract excerpt

BACKGROUND: Skin cutaneous melanoma (SKCM) is a highly aggressive and malignant tumor that arises from the malignant transformation of melanocytes. In light of the limitations of existing treatment modalities, there is a pressing need to identify new drug targets for SKCM. Aryl-hydrocarbon receptor nuclear translocator-like (ARNTL), also known as Bmal1, is a gene that has been linked to the onset and progression...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell death mechanisms and regulation
• Share to Cytokine Signaling Pathways and Interactions
• Share to Melanoma and MAPK Pathways